A photo of Sanofi corporate office sign in building atrium
A photo of Sanofi corporate office sign in building atrium
… Sanofi Reportedly Assessing Divestiture Options For Consumer Healthcare Unit …


Revenue from the possible spinoff, joint venture or outright sale of would reduce $28 billion debt load

Pivotal Elements:

Sanofi’s consumer healthcare unit is a global enterprise that generates about $5 billion in annual sales

Senior leadership implies it is seeking to better focus its global operations through deploying its clinical and financial resources into advanced life sciences

The company’s debt load of $28 billion is manageable but to improve earnings and better position the company for additional acquisitions in the future a spinoff or partial sale of non-pivotal assets is a strategic move

There is speculation in the investor, healthcare and consumer product business communities that Sanofi may form up its consumer healthcare products business unit as a separate spinoff, enjoin it through a partnership with another organization or sell it outright to another company.

Sanofi Consumer Products Division Has Global Consumer Markets Reach

  • Allegra
  • Aspercreme
  • Cortizone-10
  • Dulcolax
  • Gold Bond
  • IcyHot
  • Kaopectate
  • Nasacort
  • Rolaids
  • Selsun blue
  • Unisom
  • Xyzal
  • Zantac

Based on its $5 billion annual sales and brand franchises’ worth along with associated assets and liabilities, it is estimated Sanofi’s consumer healthcare business unit could be valued as high as just over $30 billion as a standalone company. Spinning the consumer health products unit off or engaging in a partnership with another company could reduce costs and free up cash for Sanofi to invest in other parts of its organization or service debt.

Sanofi Multinational Corporate Structure

  • General Medicines and Emerging Markets
  • Specialty Care ( Sanofi Genzyme )
  • Vaccines ( Sanofi Pasteur )
  • Consumer
  • Diabetes & Cardiovascular

Sanofi Reinvesting In Existing Pharmaceutical Business Or Engineering Other Healthcare Acquisitions

  • Lantus / insulin glargine ( diabetes care/endocrinology )
  • Aubagio / terifluonide ( multiple sclerosis/neurology )
  • Lovenox / enoxaparin sodium ( anticoagulant/cardiology )
  • Plavix / clopidogrel ( coronary artery disease, peripheral artery disease/cardiology )
  • Toujeo / insulin glargine ( diabetes care/endocrinology )

Sanofi’s Significant Debt Load May Need More Attention

Sanofi Well Experienced In Large Scale Acquisitions And Divestitures

  • 2018: Ablynx, a nano antibody biotech company, is acquired by Sanofi for $4.8 billion
  • 2018: Bioverativ, a hemophilia drug developer, is bought by Sanofi for $11.6 billion
  • 2018: Sanofi sells its generic drug unit Zentiva to private equity concern Advent International for $2.2 billion
  • 2011: Sanofi acquires biotech leader Genzyme for $20 billion

Sanofi’s Partial Or Complete Consumer Unit Divestiture Options

Moving Forward, Sanofi Competitors, Suitors And Other Stakeholders Have Much To Speculate On

Sanofi photo was taken by Christian Hartmann of Reuters ( Paris, France )

Thank you for reading this story

Read my other articles about medical and healthcare business trends, content marketing and digital strategy, brand and product management, consumer wellness, managed care and market access strategy. Contact me today for your healthcare content writing and content strategy needs.

I have over 20 years of experience in the healthcare industry producing valuable healthcare content for audiences and customers spanning physicians, nurses, pharmacists plus pharmaceutical companies, medical technology manufacturers, healthcare provider organizations, managed care, investors, consumers and other stakeholders.

Visit and connect…




Google My Business

As a healthcare content writer, my work aligns with an organization’s voice, brand, SEO elements, marketplace and objectives. It establishes trust in their company and recognized value in its products and services that generates revenue.

This experience was earned through working at Walgreens, Pfizer, AbelsonTaylor, TAP (Takeda Abbott Partnership), Hospira Worldwide and Boston Software Systems. ​

To a large degree, my professional interests emulate my family which includes doctors, nurses, physician assistants and other clinicians plus those that are working in healthcare administration and commercial enterprises.

Bare Sky Marketing LinkedIn Business Profile

Written by

Authentic, fact-based healthcare content marketing writing for medical, business, academic, patient and consumer audiences https://www.BareSkyMarketing.com/

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store